GEJ Signet Ring Cell with Skip Lesion to Mid Esophagus Post Neoadjuvant (FLOT-4)
Received Date: Jan 31, 2023 / Published Date: Feb 28, 2023
Abstract
Signet ring cells consider one of the rare diagnosis that can be managed among the oncological diseases. Confined on poor prognosis and advancement of their stage. Not seems to be affected properly with the chemotherapy. And still the surgical option is the best in operable cases to decrease the burden of the disease.
Keywords: Esophagus; Gastric; EGJ; Neoadjuvant therapy; Signet ring cells
Citation: Sindy A, Batouk A, Alamoudi F, Albaroudi A (2023) GEJ Signet Ring Cell with Skip Lesion to Mid Esophagus Post Neoadjuvant (FLOT-4). J Gastrointest Dig Syst.13:733.
Copyright: © 2023 Sindy A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 1612
- [From(publication date): 0-2023 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 1521
- PDF downloads: 91
